世界のレナリドミドAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Lenalidomide API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL0275 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はレナリドミドAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。レナリドミドAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（レナリドマイドカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・レナリドミドAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・レナリドミドAPIの種類別市場規模：純度≥98％、純度<98％ ・レナリドミドAPIの用途別市場規模：レナリドマイドカプセル、その他 ・北米のレナリドミドAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのレナリドミドAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのレナリドミドAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のレナリドミドAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのレナリドミドAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory、Shilpa Medicare Limited、Biocon Limited、Sun Pharmaceutical Industries Ltd.、Shenzhen Haorui、Mac-Chem Products (India) Pvt.Ltd ・レナリドミドAPIのバリューチェーン・販売チャネル分析 ・レナリドミドAPIの世界市場動向

Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.

Market Analysis and Insights: Global Lenalidomide API Market
The global Lenalidomide API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Lenalidomide API Scope and Segment
Lenalidomide API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lenalidomide API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Lenalidomide capsules Others By Company Dr. Reddy’s Laboratories Ltd. Johnson Matthey PLC Changzhou Pharmaceutical Factory Shilpa Medicare Limited Biocon Limited Sun Pharmaceutical Industries Ltd. Shenzhen Haorui Mac-Chem Products (India) Pvt.Ltd Production by Region India Europe China Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Lenalidomide API Product Introduction
1.2 Market by Type
1.2.1 Global Lenalidomide API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Lenalidomide API Market Size Growth Rate by Application 1.3.2 Lenalidomide capsules 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Lenalidomide API Production 2.1 Global Lenalidomide API Production Capacity (2016-2027) 2.2 Global Lenalidomide API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Lenalidomide API Production by Region 2.3.1 Global Lenalidomide API Historic Production by Region (2016-2021) 2.3.2 Global Lenalidomide API Forecasted Production by Region (2022-2027) 2.4 India 2.5 Europe 2.6 China 3 Global Lenalidomide API Sales in Volume & Value Estimates and Forecasts 3.1 Global Lenalidomide API Sales Estimates and Forecasts 2016-2027 3.2 Global Lenalidomide API Revenue Estimates and Forecasts 2016-2027 3.3 Global Lenalidomide API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Lenalidomide API Regions by Sales 3.4.1 Global Top Lenalidomide API Regions by Sales (2016-2021) 3.4.2 Global Top Lenalidomide API Regions by Sales (2022-2027) 3.5 Global Top Lenalidomide API Regions by Revenue 3.5.1 Global Top Lenalidomide API Regions by Revenue (2016-2021) 3.5.2 Global Top Lenalidomide API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Lenalidomide API Production Capacity by Manufacturers 4.2 Global Lenalidomide API Sales by Manufacturers 4.2.1 Global Top Lenalidomide API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Lenalidomide API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Lenalidomide API Sales in 2020 4.3 Global Lenalidomide API Revenue by Manufacturers 4.3.1 Global Top Lenalidomide API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Lenalidomide API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Lenalidomide API Revenue in 2020 4.4 Global Lenalidomide API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Lenalidomide API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Lenalidomide API Sales by Type 5.1.1 Global Lenalidomide API Historical Sales by Type (2016-2021) 5.1.2 Global Lenalidomide API Forecasted Sales by Type (2022-2027) 5.1.3 Global Lenalidomide API Sales Market Share by Type (2016-2027) 5.2 Global Lenalidomide API Revenue by Type 5.2.1 Global Lenalidomide API Historical Revenue by Type (2016-2021) 5.2.2 Global Lenalidomide API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Lenalidomide API Revenue Market Share by Type (2016-2027) 5.3 Global Lenalidomide API Price by Type 5.3.1 Global Lenalidomide API Price by Type (2016-2021) 5.3.2 Global Lenalidomide API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Lenalidomide API Sales by Application 6.1.1 Global Lenalidomide API Historical Sales by Application (2016-2021) 6.1.2 Global Lenalidomide API Forecasted Sales by Application (2022-2027) 6.1.3 Global Lenalidomide API Sales Market Share by Application (2016-2027) 6.2 Global Lenalidomide API Revenue by Application 6.2.1 Global Lenalidomide API Historical Revenue by Application (2016-2021) 6.2.2 Global Lenalidomide API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Lenalidomide API Revenue Market Share by Application (2016-2027) 6.3 Global Lenalidomide API Price by Application 6.3.1 Global Lenalidomide API Price by Application (2016-2021) 6.3.2 Global Lenalidomide API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Lenalidomide API Market Size by Type 7.1.1 North America Lenalidomide API Sales by Type (2016-2027) 7.1.2 North America Lenalidomide API Revenue by Type (2016-2027) 7.2 North America Lenalidomide API Market Size by Application 7.2.1 North America Lenalidomide API Sales by Application (2016-2027) 7.2.2 North America Lenalidomide API Revenue by Application (2016-2027) 7.3 North America Lenalidomide API Sales by Country 7.3.1 North America Lenalidomide API Sales by Country (2016-2027) 7.3.2 North America Lenalidomide API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Lenalidomide API Market Size by Type 8.1.1 Europe Lenalidomide API Sales by Type (2016-2027) 8.1.2 Europe Lenalidomide API Revenue by Type (2016-2027) 8.2 Europe Lenalidomide API Market Size by Application 8.2.1 Europe Lenalidomide API Sales by Application (2016-2027) 8.2.2 Europe Lenalidomide API Revenue by Application (2016-2027) 8.3 Europe Lenalidomide API Sales by Country 8.3.1 Europe Lenalidomide API Sales by Country (2016-2027) 8.3.2 Europe Lenalidomide API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Lenalidomide API Market Size by Type 9.1.1 Asia Pacific Lenalidomide API Sales by Type (2016-2027) 9.1.2 Asia Pacific Lenalidomide API Revenue by Type (2016-2027) 9.2 Asia Pacific Lenalidomide API Market Size by Application 9.2.1 Asia Pacific Lenalidomide API Sales by Application (2016-2027) 9.2.2 Asia Pacific Lenalidomide API Revenue by Application (2016-2027) 9.3 Asia Pacific Lenalidomide API Sales by Region 9.3.1 Asia Pacific Lenalidomide API Sales by Region (2016-2027) 9.3.2 Asia Pacific Lenalidomide API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Lenalidomide API Market Size by Type 10.1.1 Latin America Lenalidomide API Sales by Type (2016-2027) 10.1.2 Latin America Lenalidomide API Revenue by Type (2016-2027) 10.2 Latin America Lenalidomide API Market Size by Application 10.2.1 Latin America Lenalidomide API Sales by Application (2016-2027) 10.2.2 Latin America Lenalidomide API Revenue by Application (2016-2027) 10.3 Latin America Lenalidomide API Sales by Country 10.3.1 Latin America Lenalidomide API Sales by Country (2016-2027) 10.3.2 Latin America Lenalidomide API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Lenalidomide API Market Size by Type 11.1.1 Middle East and Africa Lenalidomide API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Lenalidomide API Revenue by Type (2016-2027) 11.2 Middle East and Africa Lenalidomide API Market Size by Application 11.2.1 Middle East and Africa Lenalidomide API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Lenalidomide API Revenue by Application (2016-2027) 11.3 Middle East and Africa Lenalidomide API Sales by Country 11.3.1 Middle East and Africa Lenalidomide API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Lenalidomide API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Johnson Matthey PLC 12.2.1 Johnson Matthey PLC Corporation Information 12.2.2 Johnson Matthey PLC Overview 12.2.3 Johnson Matthey PLC Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Johnson Matthey PLC Lenalidomide API Product Description 12.2.5 Johnson Matthey PLC Recent Developments 12.3 Changzhou Pharmaceutical Factory 12.3.1 Changzhou Pharmaceutical Factory Corporation Information 12.3.2 Changzhou Pharmaceutical Factory Overview 12.3.3 Changzhou Pharmaceutical Factory Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Changzhou Pharmaceutical Factory Lenalidomide API Product Description 12.3.5 Changzhou Pharmaceutical Factory Recent Developments 12.4 Shilpa Medicare Limited 12.4.1 Shilpa Medicare Limited Corporation Information 12.4.2 Shilpa Medicare Limited Overview 12.4.3 Shilpa Medicare Limited Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Shilpa Medicare Limited Lenalidomide API Product Description 12.4.5 Shilpa Medicare Limited Recent Developments 12.5 Biocon Limited 12.5.1 Biocon Limited Corporation Information 12.5.2 Biocon Limited Overview 12.5.3 Biocon Limited Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Biocon Limited Lenalidomide API Product Description 12.5.5 Biocon Limited Recent Developments 12.6 Sun Pharmaceutical Industries Ltd. 12.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information 12.6.2 Sun Pharmaceutical Industries Ltd. Overview 12.6.3 Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Description 12.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments 12.7 Shenzhen Haorui 12.7.1 Shenzhen Haorui Corporation Information 12.7.2 Shenzhen Haorui Overview 12.7.3 Shenzhen Haorui Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Shenzhen Haorui Lenalidomide API Product Description 12.7.5 Shenzhen Haorui Recent Developments 12.8 Mac-Chem Products (India) Pvt.Ltd 12.8.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information 12.8.2 Mac-Chem Products (India) Pvt.Ltd Overview 12.8.3 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Description 12.8.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Lenalidomide API Industry Chain Analysis 13.2 Lenalidomide API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Lenalidomide API Production Mode & Process 13.4 Lenalidomide API Sales and Marketing 13.4.1 Lenalidomide API Sales Channels 13.4.2 Lenalidomide API Distributors 13.5 Lenalidomide API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Lenalidomide API Industry Trends 14.2 Lenalidomide API Market Drivers 14.3 Lenalidomide API Market Challenges 14.4 Lenalidomide API Market Restraints 15 Key Finding in The Global Lenalidomide API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Lenalidomide API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Lenalidomide API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Lenalidomide API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Lenalidomide API Production by Region (2016-2021) & (Ton)
Table 7. Global Lenalidomide API Production Market Share by Region (2016-2021)
Table 8. Global Lenalidomide API Production by Region (2022-2027) & (Ton)
Table 9. Global Lenalidomide API Production Market Share by Region (2022-2027)
Table 10. Global Lenalidomide API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Lenalidomide API Sales by Region (2016-2021) & (Ton)
Table 12. Global Lenalidomide API Sales Market Share by Region (2016-2021)
Table 13. Global Lenalidomide API Sales by Region (2022-2027) & (Ton)
Table 14. Global Lenalidomide API Sales Market Share by Region (2022-2027)
Table 15. Global Lenalidomide API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Lenalidomide API Revenue Market Share by Region (2016-2021)
Table 17. Global Lenalidomide API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Lenalidomide API Revenue Market Share by Region (2022-2027)
Table 19. Global Lenalidomide API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Lenalidomide API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Lenalidomide API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Lenalidomide API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Lenalidomide API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Lenalidomide API Sales Share by Manufacturers (2016-2021)
Table 25. Global Lenalidomide API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Lenalidomide API Revenue Share by Manufacturers (2016-2021)
Table 27. Lenalidomide API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Lenalidomide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lenalidomide API as of 2020)
Table 30. Lenalidomide API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Lenalidomide API Product Offered
Table 32. Date of Manufacturers Enter into Lenalidomide API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 35. Global Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 36. Global Lenalidomide API Sales Share by Type (2016-2021)
Table 37. Global Lenalidomide API Sales Share by Type (2022-2027)
Table 38. Global Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Lenalidomide API Revenue Share by Type (2016-2021)
Table 41. Global Lenalidomide API Revenue Share by Type (2022-2027)
Table 42. Lenalidomide API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Lenalidomide API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 45. Global Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 46. Global Lenalidomide API Sales Share by Application (2016-2021)
Table 47. Global Lenalidomide API Sales Share by Application (2022-2027)
Table 48. Global Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Lenalidomide API Revenue Share by Application (2016-2021)
Table 51. Global Lenalidomide API Revenue Share by Application (2022-2027)
Table 52. Lenalidomide API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Lenalidomide API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 55. North America Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 56. North America Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 59. North America Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 60. North America Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Lenalidomide API Sales by Country (2016-2021) & (Ton)
Table 63. North America Lenalidomide API Sales by Country (2022-2027) & (Ton)
Table 64. North America Lenalidomide API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Lenalidomide API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Lenalidomide API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Lenalidomide API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Lenalidomide API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Lenalidomide API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Lenalidomide API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Lenalidomide API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Lenalidomide API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Lenalidomide API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Lenalidomide API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Lenalidomide API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Lenalidomide API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Lenalidomide API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Lenalidomide API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Lenalidomide API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Lenalidomide API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Lenalidomide API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Lenalidomide API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Lenalidomide API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Lenalidomide API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Lenalidomide API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Lenalidomide API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Lenalidomide API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Lenalidomide API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Lenalidomide API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Johnson Matthey PLC Corporation Information
Table 120. Johnson Matthey PLC Description and Major Businesses
Table 121. Johnson Matthey PLC Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Johnson Matthey PLC Lenalidomide API Product
Table 123. Johnson Matthey PLC Recent Development
Table 124. Changzhou Pharmaceutical Factory Corporation Information
Table 125. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 126. Changzhou Pharmaceutical Factory Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Changzhou Pharmaceutical Factory Lenalidomide API Product
Table 128. Changzhou Pharmaceutical Factory Recent Development
Table 129. Shilpa Medicare Limited Corporation Information
Table 130. Shilpa Medicare Limited Description and Major Businesses
Table 131. Shilpa Medicare Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Shilpa Medicare Limited Lenalidomide API Product
Table 133. Shilpa Medicare Limited Recent Development
Table 134. Biocon Limited Corporation Information
Table 135. Biocon Limited Description and Major Businesses
Table 136. Biocon Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Biocon Limited Lenalidomide API Product
Table 138. Biocon Limited Recent Development
Table 139. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 140. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 141. Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Sun Pharmaceutical Industries Ltd. Lenalidomide API Product
Table 143. Sun Pharmaceutical Industries Ltd. Recent Development
Table 144. Shenzhen Haorui Corporation Information
Table 145. Shenzhen Haorui Description and Major Businesses
Table 146. Shenzhen Haorui Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Shenzhen Haorui Lenalidomide API Product
Table 148. Shenzhen Haorui Recent Development
Table 149. Mac-Chem Products (India) Pvt.Ltd Corporation Information
Table 150. Mac-Chem Products (India) Pvt.Ltd Description and Major Businesses
Table 151. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product
Table 153. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Lenalidomide API Distributors List
Table 157. Lenalidomide API Customers List
Table 158. Lenalidomide API Market Trends
Table 159. Lenalidomide API Market Drivers
Table 160. Lenalidomide API Market Challenges
Table 161. Lenalidomide API Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Lenalidomide API Product Picture
Figure 2. Global Lenalidomide API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Lenalidomide API Market Share by Application in 2020 & 2027
Figure 6. Lenalidomide capsules
Figure 7. Others
Figure 8. Lenalidomide API Report Years Considered
Figure 9. Global Lenalidomide API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Lenalidomide API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Lenalidomide API Production Market Share by Region (2016-2021)
Figure 12. Global Lenalidomide API Production Market Share by Region (2022-2027)
Figure 13. Lenalidomide API Production Growth Rate in India (2016-2027) & (Ton)
Figure 14. Lenalidomide API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Lenalidomide API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Global Lenalidomide API Sales 2016-2027 (Ton)
Figure 17. Global Lenalidomide API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Lenalidomide API Revenue 2016-2027 (US$ Million)
Figure 19. Global Lenalidomide API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 20. Global Lenalidomide API Sales Market Share by Region (2016-2021)
Figure 21. Global Lenalidomide API Sales Market Share by Region (2022-2027)
Figure 22. North America Lenalidomide API Sales YoY (2016-2027) & (Ton)
Figure 23. North America Lenalidomide API Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Europe Lenalidomide API Sales YoY (2016-2027) & (Ton)
Figure 25. Europe Lenalidomide API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Asia-Pacific Lenalidomide API Sales YoY (2016-2027) & (Ton)
Figure 27. Asia-Pacific Lenalidomide API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Latin America Lenalidomide API Sales YoY (2016-2027) & (Ton)
Figure 29. Latin America Lenalidomide API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Middle East & Africa Lenalidomide API Sales YoY (2016-2027) & (Ton)
Figure 31. Middle East & Africa Lenalidomide API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Lenalidomide API Sales in 2020
Figure 33. The Top 10 and Top 5 Players Market Share by Lenalidomide API Revenue in 2020
Figure 34. Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Global Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 36. Global Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 37. Global Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 38. Global Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 39. North America Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 40. North America Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 41. North America Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 42. North America Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 43. North America Lenalidomide API Sales Share by Country (2016-2027)
Figure 44. North America Lenalidomide API Revenue Share by Country (2016-2027)
Figure 45. United States Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 46. Canada Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 47. Europe Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 48. Europe Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 49. Europe Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 50. Europe Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 51. Europe Lenalidomide API Sales Share by Country (2016-2027)
Figure 52. Europe Lenalidomide API Revenue Share by Country (2016-2027)
Figure 53. Germany Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 54. France Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 55. U.K. Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 56. Italy Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 57. Russia Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 58. Asia Pacific Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 59. Asia Pacific Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 60. Asia Pacific Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 61. Asia Pacific Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 62. Asia Pacific Lenalidomide API Sales Share by Region (2016-2027)
Figure 63. Asia Pacific Lenalidomide API Revenue Share by Region (2016-2027)
Figure 64. China Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 65. Japan Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 66. South Korea Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 67. India Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 68. Australia Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 69. China Taiwan Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 70. Indonesia Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 71. Thailand Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 72. Malaysia Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 73. Latin America Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 74. Latin America Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 75. Latin America Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 76. Latin America Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 77. Latin America Lenalidomide API Sales Share by Country (2016-2027)
Figure 78. Latin America Lenalidomide API Revenue Share by Country (2016-2027)
Figure 79. Mexico Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 80. Brazil Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 81. Argentina Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Lenalidomide API Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Lenalidomide API Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Lenalidomide API Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Lenalidomide API Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Lenalidomide API Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Lenalidomide API Revenue Share by Country (2016-2027)
Figure 88. Turkey Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Lenalidomide API Revenue (2016-2027) & (US$ Million)
Figure 91. Lenalidomide API Value Chain
Figure 92. Lenalidomide API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---